Skip to main content
Premium Trial:

Request an Annual Quote

New York Approves Foundation Medicine to Offer Cancer Sequencing Tests

NEW YORK (GenomeWeb) – The New York State Department of Health has given its approval to Foundation Medicine to perform its FoundationOne and FoundationOne Heme tests on residents of New York State.

FoundationOne is a targeted genomic sequencing test for solid tumors that profiles the coding regions of 236 cancer-related genes, as well as 47 introns from 19 other genes for alterations associated with existing and experimental molecularly targeted therapies.

FoundationOne Heme specifically targets hematologic cancers such as leukemia, lymphoma, and myeloma, as well as sarcomas and pediatric cancers to guide treatment options for patients based on the genomic profiles of their cancer. The test involves sequencing of 405 full genes, select introns of another 31 genes, and RNA sequencing targeting 265 genes that are validated molecular targets for therapy or unambiguous drivers of oncogenesis in these cancers based on current knowledge.

According to Foundation Medicine, the two tests are the only fully informative genomic profiles to be approved by New York for the detection of all classes of genomic alterations, including base pair substitutions, insertions and deletions, copy number alterations, and gene rearrangements.

Prior to this approval, the two tests were offered under conditional approval to physicians and their patients in New York.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.